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Abstract
Arterial stiffness is a reliable prognostic parameter for cardiovascular diseases. The effect of change in arterial stiffness can 
be measured by the change of the pulse wave velocity (PWV). The Complior system is widely used to measure PWV between 
the carotid and radial arteries by means of piezoelectric clips placed around the neck and the wrist. The Biopac system is an 
easier to use alternative that uses ECG and simple optical sensors to measure the PWV between the heart and the fingertips, 
and thus extends a bit more to the peripheral vasculature compared to the Complior system. The goal of this study was to 
test under various conditions to what extent these systems provide comparable and correlating values. 25 Healthy volunteers, 
20–30 years old, were measured in four sequential position: sitting, lying, standing and sitting. The results showed that the 
Biopac system measured consistently and significantly lower PWV values than the Complior system, for all positions. Cor-
relation values and Bland–Altman plots showed that despite the difference in PWV magnitudes obtained by the two systems 
the measurements did agree well. Which implies that as long as the differences in PWV magnitudes are taken into account, 
either system could be used to measure PWV changes over time. However, when basing diagnosis on absolute PWV values, 
one should be very much aware of how the PWV was measured and with what system.
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1 Introduction
Arterial stiffness is a reliable prognostic parameter for car-
diovascular morbidity and mortality in adults. In particu-
lar, this is the case in patients with renal disease, diabe-
tes mellitus or hypertension and in elderly patients [1–4]. 
Cardiovascular disease (CVD) is worldwide the number 
one cause of death. Smoking, unhealthy diet, physical inac-
tivity and harmful use of alcohol are the most important 
behavioural risk factors of CVD. These behavioural risks 
may lead to hypertension, diabetes, obesity, heart failure, or 
atherosclerosis. Most of these phenomena are related to an 
increase in arterial stiffness.
Arterial stiffness is a measure of the capability of an 
artery to expand and contract in response to local blood pres-
sure changes and is the inverse of arterial compliance. The 
compliance, and therefore the volume change in response 
to a blood pressure change, in a stiff vessel is reduced 
compared to a healthy vessel. The effect of reduced com-
pliance is a decreased propagation time of pressure pulse 
waves (PWs) through the vessels and thus an increase of 
the velocity of the PW. The relationship between this pulse 
wave velocity (PWV) and the compliance of the vessel wall 
is described in the MoensKorteweg equation [5]:
 where Einc is the incremental elastic modulus, h is the wall 
thickness, and r the radius of the vessel. The symbol ρ rep-
resents the density of blood.
PWV measurements are widely used as an index of arte-
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risk. PWV measurements are generally simple, accurate and 
highly reproducible [7, 8]. In clinical practice, several inva-
sive and non-invasive measurement techniques are readily 
available to measure PWV. Two of such techniques, equally 
often used in clinical practice by the Erasmus Medical Cen-
tre in Rotterdam, the Netherlands, are the Complior (Alam 
Medical, Vincennes, France), using piezoelectric sensors 
[9], and the Biopac (Biopac Systems, Inc, USA), using a 
photoplethysmography (PPG) sensor and ECG. These tech-
niques are generally used to non-invasively measure the 
PWV in the big arteries over a long trajectory.
The Complior system is used to measure PWV between 
the carotid and radial arteries by means of piezoelectric-clips 
placed around the neck and the wrist. The Biopac system 
is an easier-to-use alternative to the Complior system, but 
it measures the PWV between the heart and the fingertips, 
and thus extends a bit more to the peripheral vasculature. 
One may expect that the two systems show good agreement, 
because the majority of the trajectory (sternoclavicular joint 
to wrist) of the arterial trajectories over which the Biopac 
and Complior systems measure PWV are identical. However, 
the trajectory for the Biopac system additionally includes 
the wrist-fingertip vasculature. Furthermore, the Biopac 
includes the heart-sternoclavicular trajectory, whereas with 
the Complior one takes the sternoclavicular-carotid tra-
jectory as an approximation for the heart-sternoclavicular 
trajectory.
While both systems are supposed to measure or approxi-
mate a PWV value for the more or less the same trajectory 
from the heart to the hand, the potentially differing physi-
ological responses of the carotid and the peripheral arteries 
may cause different PWV measurement outcomes. The baro-
receptor reflex is one of the body’s homeostatic mechanisms 
that helps to maintain blood pressure at nearly constant lev-
els [10] by detecting blood pressure using the baroreceptors 
located in the walls of the carotid arteries. If one suddenly 
rises from a lying position, gravity pulls the blood in the 
direction of the legs, which could endanger the blood flow 
to the brain. As a response, the baroreceptor reflex causes 
the peripheral veins to be squeezed and the carotid arteries 
to be widened to aid the blood flow to the brain. Therefore 
one may expect that depending on the measurement situa-
tions the PWV change measured with the Complior system 
will oppose the PWV measured with the Biopac system if 
the baroreceptor reflex is invoked.
So while both systems are aimed at providing a similar 
measure of vascular condition and while the trajectories over 
which they measure PWV largely overlap, there are various 
reasons why it is unclear whether they will provide similar 
measurement outcomes. To the best of our knowledge, there 
are no reports about the agreement between PWV values 
measured using the Complior system or the Biopac system. 
Yet, in clinical practice it is crucial to know whether using 
different devices for the same purpose provides the same 
outcome. One would never accept it if measuring a heart 
rate using ECG versus using a pulse oximeter on the finger 
would provide a 30 bpm difference. Therefore, the goal of 
this health technology assessment was to test under various 
conditions to what extent these systems provide comparable 
values and to what extent these values correlate.
2  Method
2.1  Study population
Twenty-five healthy volunteers, 20–30 years old, without 
any known history of atherosclerosis associated diseases 
(such as diabetes mellitus, hypertension, coronary artery 
disease, stroke, renal disorder), or injuries at the upper limbs 
were included in this study after obtaining written informed 
consent from the subject. This study was approved by the 
medical ethics committee of Erasmus University Medical 
Center Rotterdam, The Netherlands (MEC-2012-139).
2.2  Protocol
The transit time of a PW traveling from within the heart to 
easily accessible locations, such as the extremities or the 
neck, consists of two components: the PW propagationtime 
from the heart through the artery to the PW measurement 
location, and the isometric contraction time of the heart 
(pre-ejection period, PEP). The PEP is known to vary with 
cardiac preload and heart rate [11–13]. Therefore, all meas-
urements were conducted in a quiet room under tranquil con-
ditions at a room temperature of 22.4 °C (SD 0.5 °C). To 
further minimize any influences of a varying PEP or cardiac 
output during the measurement, the subjects were instructed 
not to talk or move during the measurement for each posi-
tion. Because caffeine, tobacco and alcohol influence the 
heart rate and cardiac output, all subjects were asked to not 
take any caffeine, tobacco or alcohol for at least 3 h prior to 
the experiment.
The measurements were conducted 4 times for each sub-
ject, each time in a different body position. In the first posi-
tion, the subject sat on a chair with both hands resting on a 
table. In the second position, the subject lied on a bed with 
both arms and hands resting along his/her body. In the third 
position, the subject stood upright with both hands hang-
ing down along his/her body. The fourth position was the 
same as the first position, to check if the PWV-value was 
reproducible.
Before the start of each measurement in each position 
the subject was kept at rest for 60 s in the requested posi-
tion. The PWV values were recorded with both of the tested 
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systems simultaneously during the entire measurement, 
which lasted up to 60 s.
2.3  Pulse wave velocity measurements 
and analyses
The PWV was measured between the carotid and radial 
arteries using the Complior system (Alam Medical, Vin-
cennes, France) and between the carotid artery and the left 
index finger tip using ECG and PPG (described below). The 
Complior system measures the PWV using piezoelectric 
sensors. For measuring the PWs on the carotid artery, a clip 
containing a piezoelectric sensor was placed on the left side 
of the neck. For measuring the PWs on the radial artery, a 
clip containing a piezoelectric sensor was placed on the left 
wrist (see Fig. 1). Both sensor signals were recorded by the 
“Complior SP” software. The distance between the sensors, 
measured in a straight line from the sternoclavicular joint to 
the styloid process of the radius, was used to approximate 
the arterial distance travelled by the PWs. Using the “Com-
plior SP” software, the foot of the PW measured at both 
locations was used to calculate the mean PWV once per 5 s.
The system used for measuring the PWV between the 
carotid artery and the left index finger tip consisted of a 
measuring device and analysis software. The measurement 
device contained one PPG-sensor (TSD200 with the 
PPG100C amplifier, Biopac Systems, Inc, Goleta, USA), 
positioned on the left index finger, and three external ECG-
leads (ECG100C amplifier, Biopac Systems, Inc, Goleta, 
USA) (see Fig. 1). The three ECG-leads were placed on the 
subject’s both wrists and right ankle. The PPG- and ECG- 
signals were simultaneously converted to digital signals 
using AcqKnowledge version 3.7.3 software (Biopac Sys-
tems, Inc, Goleta, USA), at a sampling frequency of 2 kHz. 
The PPG-signal was filtered with a fourth-order low pass 
Butterworth filter with a cut-off frequency of 9 Hz using 
Matlab R2010a (The MathWorks, Inc., Matick, MA, USA). 
The PWV was determined by dividing the distance between 
the PPG-sensor on the left index finger and the sternoclav-
icular joint (D) by the calculated time-difference between 









where n is the sequence number of the heartbeats. The 
R-peaks in the ECG were found using the off-the-shelf Mat-
lab function ‘R-peakdetect’ [14]. The maximum of the sec-
ond derivative of each PW was taken as the foot of the PW 
 (PPGfoot) and the corresponding time was indicated as (
tPPGfoot (n)
)
 [15]. The utilized PPG-sensor was quite sensi-
tive for motion and positioning artefacts, which sometimes 
distorted the shapes of the PWs in a way that they were 
rendered unsuitable for further analysis. Therefore, a cus-
tom-made Matlab algorithm, called ‘7Step PW-Filter’, was 
implemented in the data analysis to filter out any PWs that 
strongly deviated in shape from a suitable PW [16] .If more 
than 50% of the PWs were filtered out for being too dis-
torted, the data-set was excluded from further analysis.
2.4  Statistical analysis
The mean PWVs +/− standard deviation (SD) over 60 s 
were calculated for each measurement technique for each 
body position. The Shapiro–Wilk test was used to check 
(2)PWVbiopac(n) =
D
tPPGfoot (n) − tECGR−peak (n)
,
Fig. 1  Schematic view of placement of the both measurement sys-
tems
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if the data was normally distributed. PWV values obtained 
using the Complior and Biopac system were compared using 
a paired samples t-test and a Bland–Altman plot was used to 
analyse the agreement between the two different PWV meas-
urement techniques. Correlation between both sitting posi-
tions (Position 1 and Position 4) were analysed using a Pear-
son Correlation test. A significance level of p-value < 0.05 
was used. A repeated measurement ANOVA with Green-
houseGeisser correction and a post hoc test with Bonferroni 
correction was used to test for any effects of the repeated 
measurements. All statistical analyses were performed using 
SPSS version 22.0 (SPSS, Inc., Chicago, IL, USA).
3  Results
Twenty-five subjects, (11 male, 14 female) were included in 
this study. The data of one male and one female subject were 
excluded from the analysis because there was too much noise 
in the signals to obtain any usable PWs. Table 1 presents the 
characteristic of the remaining study population. For posi-
tions 1, 2 and 4 (sitting 1, lying, sitting 2) the ‘7Step PW-
Filter’ filtered out none of the PWs. For Position 3 (standing) 
there were 8 datasets with over 50% unsuitable PWs, which 
were therefore excluded from further analysis. In the remain-
ing 15 datasets, the median percentage of unsuitable PWs 
that were filtered out was 2.2%  (Q1 = 0% and  Q3 = 36.6%).
The means and SDs for the  PWVcomplior and  PWVbiopac 
for the four different positions are listed in Table 2, as well 
as the results of the paired samples t-test. Significant dif-
ferences were found for each position between  PWVcomplior 
and  PWVbiopac.
Figure 2 shows a boxplot of  PWVcomplior and  PWVbiopac 
for each position. The data consistently showed that 
 PWVbiopac was much lower than  PWVcomplior.
Figure 3 and Table 3 present the Bland–Altman value 
and plot showing good agreement between the two PWV 
measurement techniques.
The Pearson correlation between sitting Positions 1 and 
4 proved to be high and significant for  PWVbiopac (0.778, 
p < 0.001). For  PWVcomplior there was no significant correla-
tion (0.141, p = 0.541).
The repeated measures ANOVA indicated that the 
four body positions were rated equally [F(3,45) = 2.47, 
p = 0.074], for the Complior. For the Biopac, the four body 
positions were not rated equally [F(3,39) = 13,1, p = 0.000]. 
The post hoc tests of the Biopac-data revealed that Position 
2 (lying) and Position 3 (standing) resulted in significantly 
higher PWV compared to Position 1 (sitting 1) (p = 0.000, 
p = 0.025, respectively). There was no significantly differ-
ence between Position 2 (lying) and Position 3 (standing) 
(p = 1.000).
Table 1  Characteristics of the study population
Variable Mean ± SD (n = 23)
Gender (m/f) 10/13
Age (years) 25 ± 3
Weight (kg) 72 ± 9
Height (m) 1.77 ± 0.08
Body mass index (kg/m2) 23.03 ± 2.72
Blood pressure (mmHg)
 Systolic 127 ± 11
 Diastolic 80 ± 9
Heart rate (bpm) 77 ± 14
Smoker, yes (%) 2 [8, 33]
Distance from sternoclavicular to wrist (cm) 69 ± 3
Distance from wrist to fingertip (cm) 17 ± 1
Table 2  Mean and standard deviation of the PWV
Position PWVcomplior (m/s) PWVbiopac (m/s) Paired sampled t-test
Sitting 1 10.2 ± 1.4 3.0 ± 0.2 t(21) = − 24.442, 
p < 0.001
Lying 9.3 ± 1.6 3.1 ± 0.2 t(19) = − 18.654, 
p < 0.001
Standing 9.8 ± 2.2 3.2 ± 0.2 t(13) = − 16.178, 
p < 0.001
Sitting 2 10.2 ± 1.1 3.0 ± 0.2 t(21) = − 31.704, 
p < 0.001
Fig. 2  Boxplot of the  PWVbiopac and  PWVcomplior, with the median as 
red line and the minimum and maximum value
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4  Discussion
This study compared PWV values measured over the 
carotid-radial artery trajectory using the Complior system 
with PWV values measured between the R-peak of the ECG 
and the arrival of the PW in the left index finger tip using 
the Biopac system in healthy volunteers in three body posi-
tions: sitting, lying and standing. The  PWVbiopac values 
were considerably lower than the  PWVcomplior-values, and 
this effect persisted in each position. This absolute differ-
ence might be explained for a minor part by the fact that 
 PWVbiopac includes the PEP, whereas  PWVcomplior does not. 
However, the PEP could account for no more than 1 m/s 
of the  PWVbiopac. Therefore, the large absolute difference 
between  PWVbiopac and  PWVcomplior may more likely be 
explained by the difference in vessel compliance between 
the two trajectories. More peripheral vessels are narrower, 
thinner walled and more compliant. Because the more 
peripherally measured  PWVbiopac showed to be lower, it 
is hypothesized that the reduced vessel stiffness and wall 
thickness (both reducing PWV) outweigh the reduced vas-
cular radii (which would increase the PWV). However, 
the  PWVcomplior-values agree with values reported in other 
studies. The mean  PWVcomplior-values (10.2 ± 1.4 m/s) were 
in the same range as those reported by Rajzer et al. [17] 
(10.1 ± 1.7 m/s). Although Raizer et al. measured PWV over 
the carotid-femoral trajectory, it is expected that PWVs over 
that trajectory will be similar to those in the carotid-radial 
trajectory, because of similar lengths and because the effects 
of differences in vessel radii and wall thicknesses are likely 
to cancel each other out, according to Eq. 1. Furthermore, 
the current results also agree with those of McEleavy, who 
measured a PWV of 9.01 ± 1.2 m/s in the carotid-radial tra-
jectory [18]. For the  PWVbiopac no other studies reporting 
PWV between the heart and a fingertip were found, however 
the time between the R-peak of the ECG and arrival of the 
foot of the PW at the fingertip (called pulse transit time) 
(283 ± 21 ms) was in the same range as reported previously 
by van Velzen et al. (273 ± 20 ms) [16] and by Kortekaas 
et al. (271 ± 28 ms) [13].
Fig. 3  Bland–Altman plots of  PWVcomplior and  PWVbiopac by the four positions. The dotted lines represent the 95% limits of agreement and the 
straight mean difference (bias) between  PWVcomplior and  PWVbiopac
Table 3  Bland–Altman
Position BIAS ± CI (m/s) % of overall 
mean PWV 
(%)
Sitting 1 7.2 ± 2.7 37.6
Lying 6.2 ± 2.9 47.0
Standing 6.6 ± 4.3 64.4
Sitting 2 7.3 ± 2.1 29.0
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Table 2 shows that the  PWVbiopac was consistently and 
significantly lower than  PWVcomplior for all positions (1–4). 
However, the Bland–Altman plots (Fig. 3) show that the bias 
is small and the values are scattered around the mean, lead-
ing to the conclusion that there is a good agreement between 
the  PWVcomplior and  PWVbiopac values, but they simply differ 
in magnitude.
The PWV was slightly, but significantly higher when lying 
or standing as compared to sitting (with no significant dif-
ference between lying and standing), when measured by the 
Biopac system over the heart-fingertip trajectory. PWV may 
increase when vessels become stiffer and narrower due to 
contraction, but although this effect could be induced when 
standing up, it is less likely to happen when lying down. 
There was no significant effect of the different positions for 
the  PWVcomplior, which suggests that the  PWVcomplior is less 
suitable to detect such small PWV changes or it is less sensi-
tive to changing positions. The Pearson correlation results 
show much better agreement between repetitions of the sit-
ting position at different moments for the Biopac system 
than for the Complior system. This suggests that when doing 
longitudinal PWV measurements, the Biopac system should 
be preferred, provided that the same position is consistently 
used during successive measurements.
When using the Biopac system, the measured PWV 
includes the PEP. The PEP is known to vary during posi-
tion changes. PEP variations caused by subject movement or 
stress were avoided during the current study. Kortekaas et al. 
showed a variability of the PEP in healthy volunteers in rest 
of 58.5 ± 13.0 ms [13]. Over the distances travelled by the 
PWs in the current study, these PEP durations could account 
for no more than 1 m/s of the  PWVbiopac. Consequently, PEP 
variations are unlikely to explain any variations in this study.
Limitations of the two tested techniques include the 
challenge of accurately positioning the sensors, and the 
discrepancy between the measured distance between the 
sensors and the actual path length travelled by the PWs. 
When measuring the PWV more locally, such as between 
the wrist and a position at the lower arm, the discrepancy 
between the distance between the sensors and the actual 
path length travelled by the PWs should diminish.
Furthermore, the utilized piezoelectric sensors in the 
Complior and PPG-sensors in the Biopac system were 
quite sensitive to motion and positioning disturbances. 
This sensitivity to disturbances poses a potential limitation 
on the usability of these techniques in clinical practice. 
Moreover, the Complior system is not always comfort-
able for the subject: use of the clip on the neck was some-
times experienced as uncomfortable, whereas the sensor 
required for the Biopac system a photoplethysmography 
sensor on the finger and three ECG-leads on the wrists and 
right ankle are more comfortable than the Complior sensor 
and are generally available in hospitals. Using this system 
could benefit patients and clinical practice. Although the 
‘7Step PW-Filter’ algorithm used to eliminate distorted 
PWs functioned well, the availability of a PPG-sensor 
less sensitive to disturbances and not requiring measur-
ing sensor distances, would greatly simplify measuring 
PWs in awake and moving patients. Obviously, this is less 
relevant when measuring PWs in patients under general 
anaesthesia.
In conclusion, this study demonstrated that PWV values 
were consistently and significantly lower when measured 
with the Biopac system than when measured with the Com-
plior system. Yet, despite the difference in absolute PWV 
values, the two systems did agree fairly well. This suggests 
that as long as the difference in PWV magnitudes are taken 
into account, either system could be used to measure PWV 
changes in time. However, when basing diagnosis on abso-
lute PWV values, one should be very much aware of how 
the PWV was measured and with what system. In the future, 
clinical practice could greatly benefit if software for calcu-
lating PWV is embedded in the commonly used anaesthesia 
monitors, enabling PWV measurements using a standard 
ECG and a standard pulse oximeter. This might allow PWV 
measurements to become a widely available diagnostic tool, 
and an easy-to-use, noninvasive, safe and quick method for 
objectively assessing arterial stiffness as a reliable prognos-
tic parameter for cardiovascular morbidity and mortality.
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